rs1555502548
Positions:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting
The NM_145239.3(PRRT2):āc.8C>Gā(p.Ala3Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000692 in 1,445,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: not found (cov: 31)
Exomes š: 0.0000069 ( 0 hom. )
Consequence
PRRT2
NM_145239.3 missense
NM_145239.3 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 3.95
Genes affected
PRRT2 (HGNC:30500): (proline rich transmembrane protein 2) This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13027933).
BS2
High AC in GnomAdExome4 at 10 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRRT2 | NM_145239.3 | c.8C>G | p.Ala3Gly | missense_variant | 2/4 | ENST00000358758.12 | NP_660282.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRRT2 | ENST00000358758.12 | c.8C>G | p.Ala3Gly | missense_variant | 2/4 | 1 | NM_145239.3 | ENSP00000351608 | P1 | |
MVP-DT | ENST00000569039.5 | n.246-2889G>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000692 AC: 10AN: 1445950Hom.: 0 Cov.: 32 AF XY: 0.00000417 AC XY: 3AN XY: 718726
GnomAD4 exome
AF:
AC:
10
AN:
1445950
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
718726
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 06, 2017 | - - |
Episodic kinesigenic dyskinesia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 04, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with PRRT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 448134). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with glycine at codon 3 of the PRRT2 protein (p.Ala3Gly). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and glycine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;T;.;.;.;.;T;.;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;.;.;T;T;T;T;T;.;T;.;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;L;.;L;.;.;L;L;.;L;L;.
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;N;.;.;N;.;.;N;.;.;.;.;.
REVEL
Benign
Sift
Pathogenic
.;D;D;.;.;D;.;.;D;.;.;.;.;.
Sift4G
Benign
.;T;D;.;.;D;.;.;D;.;.;D;.;.
Polyphen
0.0010, 0.0030
.;.;B;B;.;B;.;.;B;B;.;B;B;.
Vest4
0.28, 0.28, 0.23
MutPred
Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);Loss of stability (P = 0.0266);
MVP
0.81
MPC
0.66
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at